Online citations, reference lists, and bibliographies.
← Back to Search

Craniopharyngioma In Adults

F. Zoicas, C. Schöfl
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary type. The later type occurs almost exclusively in adult patients. The presenting symptoms develop over years and display a wide spectrum comprising visual, endocrine, hypothalamic, neurological, and neuropsychological manifestations. Currently, the main treatment option consists in surgical excision followed by radiation therapy in case of residual tumor. Whether gross total or partial resection should be preferred has to be balanced on an individual basis considering the extent of the tumor (e.g., hypothalamic invasion). Although the overall long-term survival is good it is often associated with substantial morbidity. Preexisting disorders are often permanent or even exacerbated by treatment. Endocrine disturbances need careful replacement and metabolic sequelae should be effectively treated. Regular follow-up by a multidisciplinary team is a prerequisite for optimal outcome of these patients.
This paper references
10.1530/EJE-09-0449
Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset craniopharyngioma on long-term GH therapy.
H. Holmer (2009)
10.1002/path.1562
Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma
K. Kato (2004)
10.1073/pnas.1101553108
Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans
C. Gaston-Massuet (2011)
10.1007/s12672-010-0041-7
CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas
M. L. Campanini (2010)
10.1016/S0140-6736(00)04006-X
Association between premature mortality and hypopituitarism
J. Tomlinson (2001)
Craniopharyngioma: radiologic and histologic findings and recurrence.
O. P. Eldevik (1996)
10.1111/j.1365-2265.2004.02196.x
High prevalence of long‐term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma
A. Pereira (2005)
10.1136/pgmj.64.754.617
Haematological, neurological and psychiatric complications of chronic hypothermia following surgery for craniopharyngioma.
A. P. Griffiths (1988)
10.1016/0360-3016(93)90227-M
20-year experience in childhood craniopharyngioma.
S. Hetelekidis (1993)
Neurosurgical treatment of craniopharyn
P. Mortini (2011)
10.1016/S0360-3016(99)00030-9
The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature.
J. Habrand (1999)
10.3171/JNS.1972.36.3.0299
Craniopharyngiomas in children and adults.
J. Hoff (1972)
10.1210/er.2009-0033
Mortality in patients with pituitary disease.
M. Sherlock (2010)
Patients cured from cran
A. A. van der Klaauw (2008)
10.5167/UZH-1853
MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.
S. Sartoretti-Schefer (1997)
10.1097/00006123-200002000-00007
Long-term outcomes for surgically resected craniopharyngiomas.
J. Duff (2000)
Conservative surgical approach in treatment strategy of craniopharyngioma: experience at a single institution in Italy.
A. Cama (2006)
10.1017/S0012162204000374
Outcome of craniopharyngioma in children: long-term complications and quality of life.
A. Poretti (2004)
10.1210/JC.2005-0185
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
J. Verhelst (2005)
10.1530/EJE.1.01877
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
P. Kendall-Taylor (2005)
10.3171/2010.1.FOCUS09315
Intracystic treatments for craniopharyngioma.
P. Steinbok (2010)
Common mutations
R. Buslei (2005)
10.3171/JNS.1990.73.1.0003
Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.
M. Yașargil (1990)
10.1111/j.1365-2265.2008.03284.x
Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls
A. A. van der Klaauw (2008)
10.1007/s00401-005-1004-x
Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
R. Buslei (2005)
The role of radiation therapy in themanagement of craniopharyngioma : a 25 - year experience and review of the literature
J. L. Habrand (1999)
10.3171/2010.11.JNS10670
Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series.
P. Mortini (2011)
10.1111/j.1365-2265.2004.02086.x
Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma
D. Smith (2004)
Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
J. Tomlinson (2001)
10.3171/JNS.2002.97.1.0003
Craniopharyngioma in adults and children: a study of 122 surgical cases.
R. van Effenterre (2002)
10.1210/JCEM.84.10.6019
Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas.
S. Webb (1999)
10.1210/JC.2002-021180
Risk factors for the development of obesity in children surviving brain tumors.
R. Lustig (2003)
10.3171/JNS.1999.90.2.0251
Surgical treatment of craniopharyngiomas: endocrinological results.
J. Honegger (1999)
10.1038/nature05487
Mechanisms linking obesity with cardiovascular disease
L. Gaal (2006)
10.1227/00006123-199412000-00001
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
H. Weiner (1994)
10.1016/0167-8140(93)90019-5
Craniopharyngioma--a long-term results following limited surgery and radiotherapy.
B. Rajan (1993)
Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
S. Sekine (2002)
10.1159/000429882
Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches.
G. Maira (1995)
Phase II trial of conformal radiation therapy for pedi
T. E. Merchant (2006)
10.1159/000120869
The role of radiation therapy in the treatment of craniopharyngioma.
W. Wara (1994)
10.1016/S0002-9440(10)64477-X
Short Communication Craniopharyngiomas of Adamantinomatous Type Harbor -Catenin Gene Mutations
S. Sekine (2002)
10.1097/00006123-199702000-00006
Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources.
J. Voges (1997)
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopitu
P. Wilton (2005)
10.1046/j.1365-2265.1999.00695.x
GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety
R. Abs (1999)
Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother
W F Regine (1993)
10.1007/s10143-009-0186-4
The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma
G. Minniti (2009)
10.3171/JNS.1983.59.3.0409
Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children.
V. Cavazzuti (1983)
10.3171/PED.2006.104.2.5
Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function.
T. Merchant (2006)
10.1111/j.1365-2265.1995.tb02664.x
Hypothalamic‐pituitary dysfunction in patients with craniopharyngioma
M. Paja (1995)
10.1016/0167-8140(93)90039-B
Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation.
W. Regine (1993)
10.1016/S0936-6555(05)81101-X
Radiotherapy for the treatment of recurrent craniopharyngioma.
C. Jose (1992)
High prevalence
A. M. Pereira (2005)
10.1093/IJE/23.3.458
International incidence of childhood brain and spinal tumours.
C. Stiller (1994)
10.3171/jns.1998.89.4.0547
The descriptive epidemiology of craniopharyngioma.
G. Bunin (1997)
10.1016/j.radonc.2010.12.001
Phosphorus-32 therapy for cystic craniopharyngiomas.
R. Barriger (2011)
10.1007/s11060-011-0693-3
Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma
H. Iwata (2011)
10.1136/bmj.1.5803.764
Craniopharyngiomas.
H. J. Hoffman (1950)
10.1007/s11060-011-0540-6
Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults
E. H. Nielsen (2011)
10.1111/j.1365-2265.2005.02231.x
Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up
N. Karavitaki (2005)
10.1016/0361-9230(81)90031-9
Thermoregulatory disorders after removal of a craniopharyngioma from the third cerebral ventricle
J. Lipton (1981)
10.1016/J.AMJMED.2004.06.035
Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage.
C. Daousi (2005)
Craniopharyngiomas of adamantinomatous
S. Sekine (2002)
Risk factors for the development
R. H. Lustig (2003)
10.1007/s00401-007-0243-4
The 2007 WHO Classification of Tumours of the Central Nervous System
D. N. Louis (2007)
Craniopharyn - giomas : a clinicopathological analysis of factors predictive of recurrence and functional outcome
H. L. Weiner (1994)
Vascular abnormalities in pediatric craniopharyn
A. K. Liu (2009)
10.32388/apxnrh
Craniopharyngioma.
M. Garnett (2007)
10.3171/JNS.1992.76.1.0047
Aggressive surgical management of craniopharyngiomas in children.
H. Hoffman (1992)
10.3171/JNS.1990.73.1.0012
Correlation of clinical and pathological features in surgically treated craniopharyngiomas.
T. E. Adamson (1990)
10.1159/000120871
Surgical management of recurrent craniopharyngiomas.
J. Wisoff (1994)
10.1016/J.IJROBP.2005.09.034
Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital.
M. Fitzek (2006)
10.1097/MOP.0b013e3282495a22
Craniopharyngioma: modern concepts in pathogenesis and treatment
M. Garrè (2007)
10.3171/PED.2007.106.1.3
Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.
S. Puget (2007)
Pediatric craniopharyn
S. Puget (2007)
Papillary craniopharyngioma: a clinicopathological study
T. B. Crotty (1995)
10.3171/JNS.1999.90.2.0237
Surgical treatment of craniopharyngiomas: experience with 168 patients.
R. Fahlbusch (1999)
10.1007/s11102-008-0137-z
Craniopharyngioma surgery
J. Honegger (2008)
10.1148/120.1.167
Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.
J. Harris (1976)
10.1016/j.ijrobp.2009.07.1693
Radiosurgery for craniopharyngioma.
A. Niranjan (2010)
The role of radiation therapy in the management of craniopharyngioma
J. L. Habrand (1999)
10.1016/j.clineuro.2009.03.009
Radiation-induced gliomas following radiotherapy for craniopharyngiomas: A case report and review of the literature
Y. Enchev (2009)
10.1210/JCEM.81.7.8675604
Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.
C. D. de Vile (1996)
10.3171/2011.6.JNS1168
Expression of carbonic anhydrase IX in craniopharyngiomas.
M. Proescholdt (2011)
10.1002/pbc.21787
Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy
A. Liu (2009)
WHO classification of tumours of the central nervous system
D. N. Louis (2007)
Total removal of craniopharyngiomas
M. G. Yasargil (1990)
Outcome of craniopharyngioma in children: longterm complications and quality
A. Poretti (2004)
MR differentiation of adamantinous
S. Sartoretti-Schefer (1997)
10.1210/JCEM.83.11.5240
Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence.
B. Bülow (1998)
10.3171/JNS.1995.83.2.0206
Papillary craniopharyngioma: a clinicopathological study of 48 cases.
T. Crotty (1995)



This paper is referenced by
10.1016/B978-0-12-416706-3.00027-1
Craniopharyngioma – Pediatric Management
H. Müller (2015)
hypothalamic obesity in adults: report of nine cases
Flavius Zoicas (2013)
10.36216/JPD.V1I2.7
Seorang penderita hipopituitarisme akibat kraniofaringioma
I. B. A. Nugraha (2018)
10.1016/B978-0-323-48563-0.00015-5
Chapter 15 – Skull Base Bone Lesions I: Imaging Technique, Developmental and Diffuse Bone Lesions
Alexandra Borges (2018)
10.1007/978-3-030-49872-6_7
Signs in Disorders of Lipid Metabolism and Obesity
A. Manni (2020)
10.4132/KoreanJPathol.2013.47.3.191
Current Concepts and Occurrence of Epithelial Odontogenic Tumors: I. Ameloblastoma and Adenomatoid Odontogenic Tumor
S. Lee (2013)
10.3892/ol.2014.2690
Craniopharyngioma: Survivin expression and ultrastructure
J. Zhu (2015)
10.1016/B978-0-323-48563-0.00015-5
Skull Base Bone Lesions II
A. Borges (2018)
10.3171/2018.10.JNS181557
Neurological and neuropsychological outcome after resection of craniopharyngiomas.
Henrik Giese (2019)
10.1016/j.clineuro.2020.105711
Adult craniopharyngioma: The role of extent of resection in tumor recurrence and long-term functional outcome
Saravanan Sadashivam (2020)
10.1007/s11060-019-03209-9
Outcomes after craniotomy for resection of craniopharyngiomas in adults: analysis of the National Surgical Quality Improvement Program (NSQIP)
Andrew K. Rock (2019)
10.1007/978-3-030-41176-3_7
Definitive Radiotherapy in Adult Population Craniopharyngiomas
L. Feuvret (2020)
10.1016/j.wneu.2018.06.121
Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Weimin Ni (2018)
10.1111/cen.14378
Women's perceptions of femininity after craniopharyngioma: a qualitative study.
Raphaëlle Eydoux (2020)
10.7560/TSLL61201
The Cause and Effect of Milton's Blindness
John Peter Rumrich (2019)
10.1097/MAJ.0000000000000365
Primary and secondary endocrinopathies found in a patient with craniopharyngioma.
A. M. Rivas (2014)
10.1016/j.wneu.2018.12.104
Recurrence of Ventral Skull Base Lesions Attributed to Tumor Seeding: A Systematic Review.
Brandon Nguyen (2018)
10.1055/a-0593-5956
Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
C. Jucá (2018)
10.3389/fendo.2012.00080
Craniopharyngioma – A Childhood and Adult Disease with Challenging Characteristics
H. Müller (2012)
Effect of Craniopharyngioma's Degree of Resection on Long Term Hormonal Outcome
M. Beltagy (2014)
10.1055/a-1217-7282
Revived Attention for Adult Craniopharyngioma.
K. C. Mende (2020)
10.1080/02688697.2020.1760207
A case report of an intra-optic recurrent craniopharyngioma.
Saeed Banaama (2020)
10.1007/s42000-018-0064-y
Non-adenomatous sellar lesions: single-centre 10-year experience
Francisco Sousa Santos (2018)
10.1007/s00701-020-04265-1
Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section
Giulia Cossu (2020)
10.1093/neuros/nyx570
Adult Craniopharyngioma: Case Series, Systematic Review, and Meta-Analysis
Charlotte Dandurand (2018)
10.1007/978-981-15-0458-7_8
Management of Patient with Craniopharyngioma
M. Srilata (2020)
10.1007/978-3-030-41176-3_9
Craniopharyngioma: Endocrinological Aspects After Surgery
M. Ilie (2020)
10.3171/2017.7.PEDS17295
Suprasellar and recurrent pediatric craniopharyngiomas: expanding indications for the extended endoscopic transsphenoidal approach.
A. Alalade (2018)
10.1007/s11060-016-2342-3
Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database
Y. Rao (2016)
10.1007/978-3-319-44444-4_5
Craniopharyngioma and Posttreatment Pituitary Dysfunction in Brain Tumors
F. Felicetti (2018)
10.1016/j.inat.2020.100804
Characteristics of ectopic recurrence of craniopharyngioma: Case report and literature review
Anzhela D. Moskalik (2020)
Semantic Scholar Logo Some data provided by SemanticScholar